Amplification of the MYCN oncogene has been observed in retinoblastoma, glioblastoma, and medulloblastoma tumors [125], and raises the possibility that TRIM32 plays a broader role in tumor suppression than previously thought. This evidence concerns the gene TRIM32 and neoplasm.